SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-24-011972
Filing Date
2024-09-16
Accepted
2024-09-16 17:28:04
Documents
6
Period of Report
2024-09-06

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A endra_pre14a.htm DEF 14A 165932
2 endra_pre14aimg1.jpg GRAPHIC 7007
3 endra_pre14aimg2.jpg GRAPHIC 7345
4 endra_pre14aimg3.jpg GRAPHIC 7352
5 endra_pre14aimg4.jpg GRAPHIC 119753
6 endra_pre14aimg5.jpg GRAPHIC 140565
  Complete submission text file 0001654954-24-011972.txt   556139
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37969 | Film No.: 241302016
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)